A comparative study in treatment of childhood vitiligo 0.03% tacrolimus versus 0.03% tacrolimus and topical steroids
Background: Vitiligo is an idiopathic, acquired cutaneous achromia, characterized by circumscribed milky white macules. It develops before the age of 20 years in 50% of the patients and before the age of 10 years in 25% of the patients. Methods: This was a 2-year, prospective, comparative study cond...
Main Authors: | Anandan Venkatesan, Rashmi Sriram, Sindhuja Balaji, T K Anandhi |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2021-01-01
|
Series: | Indian Journal of Paediatric Dermatology |
Subjects: | |
Online Access: | http://www.ijpd.in/article.asp?issn=2319-7250;year=2021;volume=22;issue=2;spage=123;epage=130;aulast=Venkatesan |
Similar Items
-
308-nm excimer lamp with 0.03% tacrolimus ointment
is safe and effective to treat children with
non-segmental vitiligo
by: Peishan Li, et al.
Published: (2022-12-01) -
Effectiveness and safety of topical tacrolimus in treatment of vitiligo
by: Ghasem Rahmatpour Rokni, et al.
Published: (2017-01-01) -
Effect of Topical Tacrolimus on Vitiligo in Children
by: Mohammed Ziaur Rahman Bhuiyan, et al.
Published: (2016-01-01) -
Comparison of the safety and efficacy of topical Tacrolimus (0.03%) versus dexamethasone (0.05%) for subepithelial infiltrates after adenoviral conjunctivitis
by: Rahul Bhargava, et al.
Published: (2019-01-01) -
COMPARATIVE EVALUATION OF TACROLIMUS 0.03% OINTMENT VS OLOPATADINE 0.2% EYE DROPS IN THE TREATMENT OF VERNAL KERATOCONJUNCTIVITIS
by: Hassan Sajjad Rathore, et al.
Published: (2021-02-01)